Journal
Med
Publication Date
6-13-2025
Volume
6
Issue
6
First Page
100608
Document Type
Open Access Publication
DOI
10.1016/j.medj.2025.100608
Rights and Permissions
Percy AK, Ryther R, Marsh ED, Neul JL, Benke TA, Berry-Kravis EM, Feyma T, Lieberman DN, Ananth AL, Fu C, Buhrfiend C, Barrett A, Doshi D, Darwish M, An D, Bishop KM, Youakim JM. Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndrome. Med. 2025 Jun 13;6(6):100608. doi: 10.1016/j.medj.2025.100608. Copyright 2025 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Recommended Citation
Percy, Alan K; Ryther, Robin; and et al., "Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndrome." Med. 6, 6. 100608 (2025).
https://digitalcommons.wustl.edu/oa_4/5325
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
